comparemela.com

Latest Breaking News On - Amitd munshi - Page 4 : comparemela.com

Pfizer to Acquire Arena Pharmaceuticals

Pfizer Inc. (NYSE: PFE) and Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that the companies have entered into a definitive agreement

United statesAmitd munshiMike gladstoneArena pharmaceuticals incCenterview partnersGuggenheim securitiesArena pharmaceuticalsPfizer incArnold porter kaye scholerEvercore groupGlobal presidentGeneral managerPfizer inflammationChief executive officerBofa securitiesPorter kaye scholer

Pfizer to buy Arena Pharmaceuticals, which has roots in San Diego, in $6 7 billion deal

Arena brings a pipeline of late-stage development drugs targeting ulcerative colitis, Crohn's disease and other ailments

United statesSan diegoPark cityAmitd munshiMike gladstoneArena pharmaceuticalsPfizer inflammation

Pfizer to Acquire Arena for $6 7B, Expanding Immuno-Inflammatory Pipeline

Pfizer has agreed to acquire Arena Pharmaceuticals for approximately $6.7 billion, in a deal designed to expand the buyer’s immuno-inflammatory disease pipeline, led by Arena’s Phase II/II lead candidate etrasimod.

United statesSan diegoBristol myers squibb zeposiaJosephp schwartzAmitd munshiMike gladstoneBristol myers squibbArena pharmaceuticalsPfizer inflammationAristea therapeuticsPark city

Arena Pharmaceuticals, inc (ARNA) Q3 2021 Earnings Call Transcript

ARNA earnings call for the period ending September 30, 2021.

United statesPatrick malloyChris howerton jefferiesNeena bitritto gargJason shayJason gerberryChris shibutaniJessica fyePrakhar agrawalYatin suneja guggenheimAlethia youngPrakhar agrawal jonestradingLaurie stelzerKennen mackayPatrick trucchioAmitd munshi

Second Genome Announces Collaboration with Arena Pharmaceuticals to Identify Gastrointestinal Biomarkers

Second Genome Announces Collaboration with Arena Pharmaceuticals to Identify Gastrointestinal Biomarkers
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Amitd munshiKarim dabbaghArena pharmaceuticals incArena pharmaceuticalsGilead sciences incSecond genomeChief executive officerGilead sciencesஅரங்கம் மருந்துகள் இன்க்அரங்கம் மருந்துகள்கிலியட் அறிவியல் இன்க்இரண்டாவது மரபணுதலைமை நிர்வாகி அதிகாரிகிலியட் அறிவியல்

vimarsana © 2020. All Rights Reserved.